Validation of a Histologic Scoring Index for C3 Glomerulopathy.


Journal

American journal of kidney diseases : the official journal of the National Kidney Foundation
ISSN: 1523-6838
Titre abrégé: Am J Kidney Dis
Pays: United States
ID NLM: 8110075

Informations de publication

Date de publication:
05 2021
Historique:
received: 24 04 2020
accepted: 06 11 2020
pubmed: 29 12 2020
medline: 11 5 2021
entrez: 28 12 2020
Statut: ppublish

Résumé

A previous study that evaluated associations of kidney biopsy findings with disease progression in patients with C3 glomerulopathy (C3G) proposed a prognostic histologic index (C3G-HI) that has not yet been validated. Our objective was to validate the performance of the C3G-HI in a new patient population. Multicenter, retrospective cohort study. 111 patients fulfilling diagnostic criteria of C3G between January 1995 and December 2019, from 33 nephrology departments belonging to the Spanish Group for the Study of Glomerular Diseases (GLOSEN). Demographic, clinical parameters, C3G-HI total activity score, and the C3G-HI total chronicity score. Time to kidney failure. Intraclass correlation coefficients and κ statistic were used to summarize inter-rater reproducibility for assessment of histopathology in kidney biopsies. The nonlinear relationships of risk of kidney failure with the total activity score and total chronicity score were modeled using Cox proportional hazards analysis that incorporated cubic splines. The study group included 93 patients with C3 glomerulonephritis and 18 with dense-deposit disease. Participants had an overall meanage of 35±22 (SD) years. Forty-eight patients (43%) developed kidney failure after a mean follow-up of 65±27 months. The overall inter-rater reproducibility was very good for the total activity score (intraclass correlation coefficient [ICC]=0.63) and excellent for total chronicity score (ICC=0.89). Baseline estimated glomerular filtration rate (eGFR), 24-hour proteinuria, and treatment with immunosuppression were the main determinants of kidney failure in a model with only clinical variables. Only tubular atrophy and interstitial fibrosis were identified as predictors in a model with histological variables. When the total activity score and total chronicity score were added to the model, only the latter was identified as an independent predictor of kidney failure. Only a subset of the kidney biopsies was centrally reviewed. Residual confounding. We validated the performance of C3G-HI as a predictor of kidney failure in patients with C3G. The total chronicity score was the principal histologic correlate of kidney failure.

Identifiants

pubmed: 33359150
pii: S0272-6386(20)31160-4
doi: 10.1053/j.ajkd.2020.11.011
pii:
doi:

Substances chimiques

Complement C3 0
Immunosuppressive Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

684-695.e1

Investigateurs

Teresa Cavero (T)
Ángel Sevillano (Á)
Eduardo Gutiérrez (E)
Enrique Morales (E)
Lucia González (L)
Rafael Camacho Galán (R)
Alejandra Gabaldón Domínguez (A)
Marta Garrido (M)
Alexandra Navarro (A)
José Antonio Cortés (JA)
Alejando Pascual Martin (A)
M Luisa Pérez-Ebri (ML)
Rocío Cabrera-Pérez (R)
Ángel Panizo Santos (Á)
Laura Yébenes Gregorio (L)
Maria Eugenia García Fernández (ME)
Javier Gimeno (J)
Pablo Cannata Ortiz (P)
Esther Roselló Sastre (E)
Ana Saiz (A)
Eduardo Salido Ruiz (E)
Rosa Rodríguez (R)
Cesáreo Corbacho Cuevas (C)
Francisco Díaz Crespo (FD)
Yolanda Arce (Y)
Maria Soledad Garcia-Cuerva Calvar (MS)
Carles Saus (C)
Carmen Guerrero Márquez (C)
Adriana García-Herrera (A)
Montserrat Gomà Gallego (M)
Dolores López Álvarez (D)
Cristina Meléndez Muñoz (C)
Macarena Centeno (M)
Belén Ferri Ñíguez (B)
Juan Mosquera Reboredo (J)
Eduardo Vázquez Martul (E)
Sofía Pérez Gutiérrez (S)

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Auteurs

Fernando Caravaca-Fontán (F)

Instituto de Investigación Hospital 12 de octubre (i+12), Madrid, Spain; Department of Medicine, Universidad Complutense de Madrid, Madrid, Spain.

Hernando Trujillo (H)

Department of Nephrology, Hospital Universitario 12 de Octubre, Madrid, Spain.

Marina Alonso (M)

Department of Pathology, Hospital Universitario 12 de Octubre, Madrid, Spain.

Montserrat Díaz-Encarnación (M)

Department of Nephrology, Fundación Puigvert, Barcelona, Spain.

Virginia Cabello (V)

Department of Nephrology, Hospital Universitario Virgen del Rocío, Sevilla, Spain.

Gema Ariceta (G)

Department of Pediatric Nephrology, Hospital Universitario Vall d'Hebron, Universidad Autónoma de Barcelona, Barcelona, Spain.

Luis F Quintana (LF)

Department of Nephrology, Hospital Clinic de Barcelona Department of Medicine, University of Barcelona, IDIBAPS, Barcelona, Spain.

Helena Marco (H)

Department of Nephrology, Hospital Universitario Germans Trias i Pujol, Badalona, Barcelona, Spain.

Xoana Barros (X)

Department of Nephrology, Hospital Universitario Doctor Josep Trueta, Gerona, Spain.

Natalia Ramos (N)

Department of Nephrology, Hospital Universitario Vall d'Hebron, Barcelona, Spain.

Nuria Rodríguez-Mendiola (N)

Department of Nephrology, Hospital Universitario Ramón y Cajal, Madrid, Spain.

Sonia Cruz (S)

Department of Nephrology, Hospital Universitario Juan Ramón Jiménez, Huelva, Spain.

Gema Fernández-Juárez (G)

Department of Nephrology, Hospital Universitario Fundación Alcorcón, Alcorcón, Madrid, Spain.

Eva Rodríguez (E)

Department of Nephrology, Hospital del Mar, Barcelona, Spain.

Francisco de la Cerda (F)

Department of Pediatric Nephrology, Hospital Universitario Virgen del Rocío, Sevilla, Spain.

Ana Pérez de José (A)

Department of Nephrology, Hospital Universitario Gregorio Marañón, Madrid, Spain.

Inmaculada López (I)

Department of Nephrology, Hospital Universitario Virgen de la Arrixaca, Murcia, Spain.

Loreto Fernández (L)

Department of Nephrology, Complejo Hospitalario de Navarra, Navarra, Spain.

Vanessa Pérez Gómez (V)

Department of Nephrology, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain.

Ana Ávila (A)

Department of Nephrology, Hospital Universitario Doctor Peset, Valencia, Spain.

Luis Bravo (L)

Department of Nephrology, Hospital Universitario A Coruña, La Coruña, Spain.

Javier Lumbreras (J)

Pediatric Nephrology Unit, Hospital Universitario Son Espases, Balearic Islands Health Research Institute (IdISBa), Palma de Mallorca, Spain.

Natalia Allende (N)

Department of Nephrology, Hospital Universitario Son Espases, Palma de Mallorca, Spain.

Maria Dolores Sanchez de la Nieta (MD)

Department of Nephrology, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain.

Teresa Olea (T)

Department of Nephrology, Hospital Universitario La Paz, Madrid, Spain.

Marta Melgosa (M)

Department of Pediatric Nephrology, Hospital Universitario La Paz, Madrid, Spain.

Ana Huerta (A)

Department of Nephrology, Hospital Universitario Puerta de Hierro, Madrid, Spain.

Rosa Miquel (R)

Department of Nephrology, Hospital Universitario Canarias, Tenerife, Spain.

Carmen Mon (C)

Department of Nephrology, Hospital Universitario Severo Ochoa, Leganés, Madrid, Spain.

Gloria Fraga (G)

Department of Pediatric Nephrology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.

Alberto de Lorenzo (A)

Department of Nephrology, Hospital Universitario de Getafe, Madrid, Spain.

Juliana Draibe (J)

Department of Nephrology, Hospital Universitario de Bellvitge, Barcelona, Spain.

Fayna González (F)

Department of Nephrology, Hospital Doctor Negrín, Gran Canaria, Spain.

Amir Shabaka (A)

Department of Nephrology, Hospital Universitario Clínico San Carlos, Madrid, Spain.

Maria Luisa Illescas (ML)

Department of Nephrology, Complejo Hospitalario Universitario de Albacete, Albacete, Spain.

Consuelo Calvo (C)

Department of Nephrology, Hospital General Universitario de Castellón, Castellón, Spain.

Victoria Oviedo (V)

Department of Nephrology, Hospital Universitario Marqués de Valdecilla, Santander, Spain.

Iara Da Silva (I)

Department of Nephrology, Fundación Puigvert, Barcelona, Spain.

Elena Goicoechea de Jorge (E)

Department of Immunlogy, Universidad Complutense de Madrid, Madrid, Spain; Centro de Investigaciones Biológicas, Consejo Superior de Investigaciones Científicas, Madrid and Centro de Investigación Biomédica en Red en Enfermedades Raras, Madrid, Spain.

Francisco Caravaca (F)

Department of Nephrology, Hospital Universitario de Badajoz, Badajoz, Spain.

Manuel Praga (M)

Instituto de Investigación Hospital 12 de octubre (i+12), Madrid, Spain; Department of Medicine, Universidad Complutense de Madrid, Madrid, Spain; Department of Nephrology, Hospital Universitario 12 de Octubre, Madrid, Spain. Electronic address: mpragat@senefro.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH